Biotech

All Articles

Former Seagen chief executive officer introduces brand-new startup Ottimo Pharma

.After antibody-drug conjugate (ADC) professional Seagen was actually sold to Pfizer in 2015 for an ...

Ironwood makes additional bid for $1B GI drug with brand-new subgroup records

.On the heels of a stage 3 succeed that neglected to blow away real estate investors, Ironwood Pharm...

Novartis inks $150M deal for autoimmune molecular adhesive

.Do not cease Monte Rosa Therapeutics now. The Boston-based biotech is having a ball after authorizi...

Jade takes exec group along with Chinook vets-- Chutes &amp Ladders

.Invite to today's Chutes &amp Ladders, our summary of substantial leadership hirings, shootings and...

Septerna goes public with upsized offering of $288M

.Commemorating his firm's upsized initial public offering (IPO), Septerna chief executive officer Je...

AbbVie makes Richter wealthier, paying for $25M to form finding pact

.AbbVie has come back to the resource of its antipsychotic giant Vraylar trying to find another hit,...

GenSight enters into ultimate full weeks of cash money path as income stream slips by of scope

.GenSight Biologics is weeks off of running out of funds. Again. The biotech just possesses enough c...

AZ licenses disposed of uncommon condition medication to Monopar Therapies

.Monopar Therapies is actually recuperating a medicine from the scrap heap of AstraZeneca's unusual ...

Arcus' new HIF-2a data in renal cancer cells mean possible advantage over Merck's Welireg, experts state

.With brand-new data out on Arcus Biosciences' experimental HIF-2a inhibitor, one team of profession...

Roche bets around $1B to expand Dyno genetics treatment distribution treaty

.After developing a gene therapy partnership with Dyno Therapies in 2020, Roche is back for addition...